 Autoantibodies
"Autoantibodies" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Antibodies that react with self-antigens (AUTOANTIGENS) of the organism that produced them.
| Descriptor ID |
D001323
|
| MeSH Number(s) |
D12.776.124.486.485.114.323 D12.776.124.790.651.114.323 D12.776.377.715.548.114.323
|
| Concept/Terms |
|
Below are MeSH descriptors whose meaning is more general than "Autoantibodies".
Below are MeSH descriptors whose meaning is more specific than "Autoantibodies".
This graph shows the total number of publications written about "Autoantibodies" by people in this website by year, and whether "Autoantibodies" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1996 | 4 | 2 | 6 | | 1997 | 0 | 1 | 1 | | 1998 | 1 | 1 | 2 | | 1999 | 9 | 2 | 11 | | 2000 | 3 | 1 | 4 | | 2001 | 3 | 4 | 7 | | 2002 | 7 | 3 | 10 | | 2003 | 5 | 4 | 9 | | 2004 | 13 | 11 | 24 | | 2005 | 7 | 9 | 16 | | 2006 | 4 | 7 | 11 | | 2007 | 13 | 8 | 21 | | 2008 | 12 | 9 | 21 | | 2009 | 15 | 17 | 32 | | 2010 | 12 | 9 | 21 | | 2011 | 19 | 7 | 26 | | 2012 | 15 | 9 | 24 | | 2013 | 22 | 10 | 32 | | 2014 | 19 | 8 | 27 | | 2015 | 17 | 20 | 37 | | 2016 | 16 | 9 | 25 | | 2017 | 21 | 21 | 42 | | 2018 | 20 | 12 | 32 | | 2019 | 21 | 17 | 38 | | 2020 | 19 | 12 | 31 | | 2021 | 16 | 18 | 34 | | 2022 | 4 | 47 | 51 | | 2023 | 5 | 49 | 54 | | 2024 | 11 | 16 | 27 | | 2025 | 15 | 16 | 31 | | 2026 | 9 | 9 | 18 |
To return to the timeline, click here.
Below are the most recent publications written about "Autoantibodies" by people in Profiles.
-
Clasen JL, Jonsdottir B, Vehik K, Lynch KF, Parikh HM, Koskenniemi JJ, Lernmark Å, Agardh D, Hagopian WA, Rewers MJ, Toppari J, Ziegler AG, Akolkar B, Krischer JP, Haller M, Elding Larsson H. Thyroid autoimmunity and the subsequent development of islet and celiac autoimmunity in the TEDDY study. Am J Epidemiol. 2026 08 05; 195(8):2111-2120.
-
Pittock SJ, Barnett MH, Bennett JL, Berthele A, de Sèze J, Levy M, Nakashima I, Oreja-Guevara C, Palace J, Paul F, Pozzilli C, Pathak R, Allen K, Parks B, Kim HJ. Long-Term Ravulizumab Efficacy and Safety in AQP4 Antibody-Positive Neuromyelitis Optica Spectrum Disorder: Final CHAMPION-NMOSD Results. Neurol Neuroimmunol Neuroinflamm. 2026 Sep; 13(5):e200609.
-
Burnett HQ, Studts C, Frost HM, Gray T, Balderas YM, Gottlieb Y, Miller R, Silva C, Felipe-Morales D, Rasmussen CG, Rewers M, OLeary S. Integrating a Research-Based Type 1 Diabetes Autoantibody Screening Protocol Into an Economically and Culturally Diverse Federally Qualified Health Center. Acad Pediatr. 2026 Aug; 26(6):103384.
-
Karakus KE, Clayton MG, Baschal EE, McDaniel KA, Yu L, Haider Z, Polsky S, Akturk HK, Gottlieb PA, Garg SK, Michels AW. Differences in Clinical Manifestations and Islet Autoantibodies by Age in Adult-Onset Type 1 Diabetes. Diabetes Care. 2026 07 01; 49(7):1194-1201.
-
Hohsfield KR, Carry P, Slack S, Repaci CT, Vanderlinden LA, Kechris K, Rewers M, Norris JM, Johnson RK. Differences in immune cell profiles around the time of islet autoimmunity seroconversion in children with and without type 1 diabetes. BMJ Open Diabetes Res Care. 2026 May 25; 14(3).
-
Wright EE, Low Wang CC, Novak LM, Shubrook JH. Misclassification of type 1 diabetes as type 2 diabetes in adults: practical guidance for screening and diagnosis for primary care providers. Postgrad Med. 2026 May; 138(4):396-407.
-
Kanack AJ, Splinter NP, Mauch EE, Tefera L, Gil MR, Jasra S, Goodwin A, Smock KJ, Ahmad H, Ashrani A, Robinson NL, Casanegra AI, Jones CG, Pechauer SM, Yttre E, Aster RH, Kohlhagen MC, Leger RR, Johns G, Murray DL, Zhou L, Wang D, Wen R, Chen D, Pruthi RK, Padmanabhan A. Pathogenic PF4/Polyanion ELISA-Negative Antibodies in HIT. Am J Hematol. 2026 Aug; 101(8):1790-1798.
-
Panicker AJ, Hinman SS, Perreau J, Aslanpour A, Williams RL, Steinke S, Quinn E, Hernandez AL, Yandamuri SS, Irani SR, Longbrake EE, O'Connor KC. Generation of Monoclonal Autoantibodies From Myelin Oligodendrocyte Glycoprotein-Specific Human B Cells Using an Optofluidic-Based Platform. Neurol Neuroimmunol Neuroinflamm. 2026 May; 13(3):e200577.
-
Kanack A, Mauch E, Roberge G, Splinter N, Gundabolu K, Wool GD, George G, Abou-Ismail MY, Smock KJ, Green DL, Coker J, Kohlhagen MC, Murray DL, Padmanabhan A. Platelet factor 4 antibody persistence and long-term pathogenicity in vaccine-induced immune thrombotic thrombocytopenia. J Thromb Haemost. 2026 07; 24(7):2514-2521.
-
Hou S, Lindholm PF, Thurman JM, Lee J, Ramsey-Goldman R, Zhao M. C4b-binding protein as an antigenic target in the pathogenesis of antiphosphatidylethanolamine autoantibodies. Proc Natl Acad Sci U S A. 2026 Mar 24; 123(12):e2528183123.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|